Market closed
IQVIA Holdings/$IQV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About IQVIA Holdings
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Ticker
$IQV
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
88,000
Website
IQVIA Holdings Metrics
BasicAdvanced
$34B
25.50
$7.49
1.48
-
Price and volume
Market cap
$34B
Beta
1.48
52-week high
$261.73
52-week low
$187.62
Average daily volume
1.5M
Financial strength
Current ratio
0.838
Quick ratio
0.731
Long term debt to equity
218.048
Total debt to equity
238.734
Interest coverage (TTM)
3.39%
Management effectiveness
Return on assets (TTM)
5.32%
Return on equity (TTM)
22.55%
Valuation
Price to earnings (TTM)
25.497
Price to revenue (TTM)
2.248
Price to book
5.54
Price to tangible book (TTM)
-2.56
Price to free cash flow (TTM)
16.378
Growth
Revenue change (TTM)
2.81%
Earnings per share change (TTM)
2.74%
3-year revenue growth (CAGR)
3.55%
3-year earnings per share growth (CAGR)
14.80%
What the Analysts think about IQVIA Holdings
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for IQVIA Holdings stock.
IQVIA Holdings Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IQVIA Holdings Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IQVIA Holdings News
AllArticlesVideos
Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation
Business Wire·2 days ago
IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
Business Wire·6 days ago
IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way
Seeking Alpha·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for IQVIA Holdings stock?
IQVIA Holdings (IQV) has a market cap of $34B as of February 27, 2025.
What is the P/E ratio for IQVIA Holdings stock?
The price to earnings (P/E) ratio for IQVIA Holdings (IQV) stock is 25.5 as of February 27, 2025.
Does IQVIA Holdings stock pay dividends?
No, IQVIA Holdings (IQV) stock does not pay dividends to its shareholders as of February 27, 2025.
When is the next IQVIA Holdings dividend payment date?
IQVIA Holdings (IQV) stock does not pay dividends to its shareholders.
What is the beta indicator for IQVIA Holdings?
IQVIA Holdings (IQV) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.